VML 670
Alternative Names: CEB 1555Latest Information Update: 31 Mar 2009
At a glance
- Originator Eli Lilly and Company
- Class Antiemetics
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Female sexual dysfunction; Male sexual dysfunction; Nausea and vomiting
Most Recent Events
- 03 Oct 2003 Vernalis Group has merged with British Biotech to form Vernalis
- 03 Oct 2003 Vernalis is no longer involved in the development of VML 670 and appears to have returned rights to Eli Lilly
- 03 Apr 2003 This compound is still in active development